Skip to main content
SpringerLink
Log in

Treatment of Paraphilic Sex Offenders

  • Chapter
  • First Online:
Emotional, Physical and Sexual Abuse

Abstract

Paraphilic disorders are characterized by recurrent, intense, sexually arousing fantasies, urges, or behaviors, over a period ≥6 months, generally involving nonhuman objects, suffering, or humiliation of oneself or one’s partner, children, or other non-consenting persons. These fantasies, urges, and behaviors produce clinically significant distress or impairments in social, occupational, and other important areas of functioning. Only a part of paraphilic behaviors may lead to sex offenses and vice versa; not all sex offenders suffer from a paraphilia. A sex offense, a major public health concern, is defined as any violation of established legal or moral codes of sexual behavior. Current treatment interventions of paraphilic sex offenders tend to integrate psychotherapy with pharmacological therapy, using psychotropic drugs and/or hormonal approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th edn: DSM-5 tm. American Psychiatric Association, Washington, DC

    Google Scholar 

  2. Thibaut F (2012) Pharmacological treatment of paraphilias. Isr J Psychiatry Relat Sci 49:297–305

    PubMed  Google Scholar 

  3. Post L, Mezey N, Maxwell N, Wilbert W (2002) The rape tax: tangible and intangible costs of sexual violence. J Interpers Violence 17:773–782

    Article  Google Scholar 

  4. Birger M, Bergman-Levy T, Asman O (2011) Treatment of sex offenders in Israeli prison settings. J Am Acad Psychiatry Law 39:100–103

    PubMed  Google Scholar 

  5. Craig LA, Browne KD, Stringer I, Hogue TE (2008) Sexual reconviction rates in the United Kingdom and actuarial risk estimates. Child Abuse Negl 32:121–138

    Article  PubMed  Google Scholar 

  6. Hanson RK, Morton KE, Harris AJ (2003) Sexual offender recidivism risk: what we know and what we need to know. Ann NY Acad Sci 989:154–166

    Article  PubMed  Google Scholar 

  7. Hanson RK, Morton-Bourgon KE (2005) The characteristics of persistent sexual offenders: a meta-analysis of recidivism studies. J Consult Clin Psychol 73:1154–1163

    Article  PubMed  Google Scholar 

  8. Garcia FD, Delavenne HG, Assumpção AF, Thibaut F (2013) Pharmacologic treatment of sex offenders with paraphilic disorder. Curr Psychiatry Rep 15:356

    Article  PubMed  Google Scholar 

  9. Thibaut F, De la Barra F, Gordon H, Cosyns P, Bradford JM, WFSBP Task Force on Sexual Disorders (2010) The World Federation of Society of biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias. J Biol Psychiatry 11:604–655

    Google Scholar 

  10. Hall RC (2007) A profile of pedophilia: definition, characteristics of offenders, recidivism, treatment outcomes, and forensic issues. Mayo Clin Proc 82:457–471

    Article  PubMed  Google Scholar 

  11. Kenworthy T, Adams CE, Bilby C, Brooks-Gordon B, Fenton M (2008) WITHDRAWN: psychological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev 4, CD004858

    PubMed  Google Scholar 

  12. Kaplan MS, Krueger RB (2012) Cognitive-behavioral treatment of the paraphilias. Isr J Psychiatry Relat Sci 49:291–296

    PubMed  Google Scholar 

  13. Losel F, Schmucker M (2005) The effectiveness of treatment for sexual offenders: a comprehensive meta-analysis. J Exp Criminol 1:117–146

    Article  Google Scholar 

  14. Kenworthy T, Adams CE, Bilby C, Brooks-Gordon B, Fenton M (2004) Psychological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev 3:CD004858

    PubMed  Google Scholar 

  15. Maletzki BM, Steinhauser C (2002) A 25-year follow-up of cognitive-behavioural therapy with 7,275 sexual offenders. Behav Modif 26:123–147

    Article  Google Scholar 

  16. Brooks-Gordon B, Bilby C, Wells H (2006) A systematic review of psychological interventions for sexual offenders I. Randomised control trials. J Forensic Psychiatry 17:442–466

    Article  Google Scholar 

  17. Belgian Advisory Commitee on Bioethics (2006) Opinion no. 39 of December 18th 2006 on hormonal treatment of sex offender. http://www.health.belgium.be/internet2Prd/groups/public/@public/@dg1/@legalmanagement/documents/ie2divers/18074794.pdf. Accessed 25 Jan 2014

  18. Khan O, Ferriter M, Huband N, Smailagic N (2009) Pharmacological interventions for those who have sexually offended or are at risk of offending (Protocol). The Cochrane Library, Issue 3

    Google Scholar 

  19. Guay DRP (2009) Drug treatment of paraphilic and nonparaphilic sexual disorders. Clin Ther 31:1–31

    Article  CAS  PubMed  Google Scholar 

  20. Adi Y, Ashcroft D, Browne K, Beech A, Fry-Smith A, Hyde C (2002) Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technol Assess 6:1–66

    CAS  PubMed  Google Scholar 

  21. Thibaut F (2011) Pharmacological treatment of sex offenders. Sexologies 20:166–168

    Article  Google Scholar 

  22. Fedoroff JP (1995) Antiandrogens vs serotonergic medications in the treatment of sex offenders: a preliminary compliance study. Can J Hum Sex 4:111–123

    Google Scholar 

  23. Meston CM, Frohlich PF (2000) The neurobiology of sexual function. Arch Gen Psychiatry 57:1012–1030

    Article  CAS  PubMed  Google Scholar 

  24. Hill A, Briken P, Kraus C, Strohm K, Berner W (2003) Differential pharmacological treatment of paraphilias and sex offenders. Int J Offender Ther Comp Criminol 47:407–421

    Article  PubMed  Google Scholar 

  25. Garcia FD, Thibaut F (2011) Current concepts in the pharmacotherapy of paraphilias. Drugs 71:771–790

    Article  CAS  PubMed  Google Scholar 

  26. Giltay EJ, Gooren LG (2009) Potential side effects of androgen deprivation treatment in sex offenders. J Am Acad Psychiatry Law 37:53–58

    PubMed  Google Scholar 

  27. Jeffcoate WJ, Matthews RW, Edwards CR, Field LH, Besser GM (1980) The effect of cyproterone acetate on serum testosterone, LH, FSH and prolactin in male sexual offenders. Clin Endocrinol 13:189–195

    Article  CAS  Google Scholar 

  28. Neuman F (1997) Pharmacology and potential use of cyproterone acetate. Horm Metab Res 9:1–13

    Article  Google Scholar 

  29. Dunsieth NW, Nelson EB, Brusman-Lovins LA, Holcomb JL, Beckman D, Welge JA et al (2004) Psychiatric and legal features of 113 men convicted of sexual offenses. J Clin Psychiatry 65:293–300

    Article  PubMed  Google Scholar 

  30. Bradford JM (2001) The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour. Can J Psychiatry 6:26–34

    Google Scholar 

  31. Raymons NC, Coleman E, Ohlerking F, Christenson GA, Miner M (1999) Psychiatric comorbidity in pedophilic sex offenders. Am J Psychiatry 156:786–788

    Google Scholar 

  32. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ III, Spack NP, Tangpricha V, Montori VM (2009) Endocrine Society. Endocrine treatment of transsexuals persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132–3154

    Article  CAS  PubMed  Google Scholar 

  33. Rosler A, Witztum E (2000) Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law Behav Sci 18:43–56

    Article  CAS  Google Scholar 

  34. Thibaut F, Cordier B, Kuhn JM (1993) Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatr Scand 87:445–450

    Article  CAS  PubMed  Google Scholar 

  35. Thibaut F, Cordier B, Kuhn JM (1996) Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment? Psychoneuroendocrinology 21:411–419

    Article  CAS  PubMed  Google Scholar 

  36. Thibaut F, Kuhn JM, Cordier B, Petit M (1998) Hormone treatment of sex offenses. Encéphale 24:132–137

    CAS  PubMed  Google Scholar 

  37. Schober JM, Kuhn PJ, Kovacs PG, Earle JH, Byrne PM, Fries RA (2005) Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav 34:691–705

    Article  PubMed  Google Scholar 

  38. Krueger RB, Kaplan MS (2001) Depot-Leuprolide Acetate for treatment of paraphilias: a report of twelve cases. Arch Sex Behav 30:409–422

    Article  CAS  PubMed  Google Scholar 

  39. Czerny JP, Briken P, Berner W (2002) Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics. Eur Psychiatry 17:104–106

    Article  PubMed  Google Scholar 

  40. Brahams D (1988) Voluntary chemical castration of a mental patient. Lancet 1:1291–1292

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sexual Medicine and Andrology Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Viale Pieraccini 6, Florence, 50139, Italy

    Alessandra D. Fisher & Mario Maggi

Authors
  1. Alessandra D. Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Maggi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Maggi .

Editor information

Editors and Affiliations

  1. Medical Department; Endocrinology Unit, Maggiore-Bellaria Hospital, Azienda-Usl Bologna, Bologna, Italy

    Giovanni Corona

  2. Department of System Medicine, University of Rome Tor Vergata, Rome, Italy

    Emmanuele A. Jannini

  3. Sexual Medicine and Andrology Unit, University of Florence, Florence, Italy

    Mario Maggi

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Fisher, A.D., Maggi, M. (2014). Treatment of Paraphilic Sex Offenders. In: Corona, G., Jannini, E., Maggi, M. (eds) Emotional, Physical and Sexual Abuse. Springer, Cham. https://doi.org/10.1007/978-3-319-06787-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06787-2_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06786-5

  • Online ISBN: 978-3-319-06787-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation